Loading...

Kelly CRISPR & Gene Editing Technology ETF

Part of Strategic Trust

Net Assets

$2.6 Million

Holdings

25 total

Top 10

76.21%

Top Holding

CRISPR Therapeutics AG

Upgrade to Starlitics PRO to access this feature

Upgrade to Starlitics PRO to access this feature

Upgrade to Starlitics PRO to access this feature